全文获取类型
收费全文 | 2904篇 |
免费 | 330篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 239篇 |
妇产科学 | 95篇 |
基础医学 | 336篇 |
口腔科学 | 68篇 |
临床医学 | 366篇 |
内科学 | 624篇 |
皮肤病学 | 58篇 |
神经病学 | 204篇 |
特种医学 | 202篇 |
外科学 | 428篇 |
综合类 | 132篇 |
一般理论 | 5篇 |
预防医学 | 176篇 |
眼科学 | 11篇 |
药学 | 89篇 |
中国医学 | 7篇 |
肿瘤学 | 76篇 |
出版年
2021年 | 41篇 |
2020年 | 19篇 |
2019年 | 36篇 |
2018年 | 66篇 |
2017年 | 68篇 |
2016年 | 56篇 |
2015年 | 50篇 |
2014年 | 76篇 |
2013年 | 106篇 |
2012年 | 108篇 |
2011年 | 129篇 |
2010年 | 112篇 |
2009年 | 96篇 |
2008年 | 100篇 |
2007年 | 101篇 |
2006年 | 97篇 |
2005年 | 74篇 |
2004年 | 64篇 |
2003年 | 52篇 |
2002年 | 57篇 |
2001年 | 78篇 |
2000年 | 81篇 |
1999年 | 39篇 |
1998年 | 81篇 |
1997年 | 68篇 |
1996年 | 72篇 |
1995年 | 76篇 |
1994年 | 51篇 |
1993年 | 60篇 |
1992年 | 92篇 |
1991年 | 90篇 |
1990年 | 81篇 |
1989年 | 75篇 |
1988年 | 75篇 |
1987年 | 61篇 |
1986年 | 67篇 |
1985年 | 69篇 |
1984年 | 66篇 |
1983年 | 35篇 |
1981年 | 28篇 |
1980年 | 26篇 |
1979年 | 40篇 |
1978年 | 20篇 |
1977年 | 22篇 |
1976年 | 24篇 |
1975年 | 22篇 |
1973年 | 28篇 |
1972年 | 22篇 |
1971年 | 25篇 |
1967年 | 17篇 |
排序方式: 共有3247条查询结果,搜索用时 0 毫秒
71.
72.
I. Dianzani L. Farinasso P. Fortina C. Camaschella R. Ponzone H-H. M. Dahl R. G. H. Cotton A. Ponzone 《Journal of inherited metabolic disease》1989,12(2):162-165
Summary Different mutations of the phenylalanine hydroxylase (PAH) gene leading to phenylketonuria (PKU) have been described associated with specific haplotypes in several European countries. In order to investigate the distribution of DNA haplotypes in Italy, restriction fragment length polymorphism (RFLP) analysis of the PAH gene was performed in nine Italian PKU patients from eight unrelated families, and in the available relatives. The analysis of eight polymorphic sites revealed haplotypes 1 and 6 in association with PKU. This pattern appears to differ from those reported for other European populations.The majority of the 14 PKU subjects studied showed compound heterozygosity for different haplotypes, as observed for other European series.RFLP analysis at the PAH locus allowed us to offer the possibility of prenatal diagnosis to six of the studied families. One prenatal diagnosis was performed and a normal fetus was diagnosed. 相似文献
73.
J F Dowsett D Vaira A R Hatfield S R Cairns A Polydorou R Frost J Croker P B Cotton R C Russell R R Mason 《Gastroenterology》1989,96(4):1180-1186
Between September 1985 and December 1987, 74 patients underwent attempted endoscopic biliary therapy using a combined percutaneous transhepatic and endoscopic transpapillary approach (combined procedure). All patients had had failed endoscopy-alone procedures and had contraindications to surgery. The indication was palliation of malignant biliary obstruction in 66 cases (41 common bile duct, 25 hilar), assistance with sphincterotomy for the removal of common bile duct stones in 6 cases, and management of benign biliary stenosis in 2 cases. The initial procedure was percutaneous transhepatic access to the biliary tree, which was successful in all but 1 case (99%). The bile duct was drained externally for an average of 3.4 days before the combined procedure. One patient died during this period from hemorrhage associated with liver puncture. Combined procedure was performed in 72 cases and was successful in 60 [53 malignant stricture (53/66 = 80%), five common duct stone (5/6 = 83%), two benign stricture (2/2 = 100%)]. Procedure-related morbidity and mortality, respectively, were 12.5% and 0% for benign disease and 36% and 3% for malignant disease. The total (initial endoscopy included) morbidity and 30-day mortality were 33% and 0%, respectively, for benign disease and 62% and 27% for malignant disease. Subsequently, stent change has been required on 16 occasions, with endoscopy-only successful in 13 (81%) and repeat combined procedure being required in three (19%). The combined procedure improves the ability of endoscopy to offer nonsurgical therapy to poor risk patients with both malignant and benign biliary disease but is associated with significant morbidity and disease-related mortality. 相似文献
74.
Early changes in phosphatidylcholine metabolism in human acute promyelocytic leukemia cells stimulated to differentiate by phorbol ester 总被引:7,自引:0,他引:7
The HL-60 leukemia cell line derived from a human acute promyelocytic leukemia is stimulated to differentiate into macrophages within 24-28 hr after exposure to the phorbol ester, 12-O-tetradecanoylphorbol-13- acetate (TPA). We studied early alterations (within 90 min of exposure to TPA) in phosphatidylcholine metabolism in HL-60 cells and found that phosphatidylcholine synthesis by methylation is phosphatidylethanolamine was inhibited in a dose-dependent fashion. In contrast, synthesis of phosphatidylcholine from endogenous choline was enhanced and correlated inversely with the degree of inhibition of the methylation pathway. Phorbol ester congeners of TPA caused similar alterations in phosphatidylcholine metabolism in direct relationship to their capacity to induce differentiation in HL-60 cells. Perturbation of phosphatidylcholine metabolism is an early membrane even in TPA- induced HL-60 cell differentiation. 相似文献
75.
DZ Loesch F Tassone J Lo HR Slater LV Hills MQ Bui PA Silburn GD Mellick 《Clinical genetics》2013,84(4):382-385
We recently reported a significant increase in the frequency of carriers of grey zone (GZ) alleles of FMR1 gene in Australian males with Parkinson's disease (PD) from Victoria and Tasmania. Here, we report data comparing an independent sample of 817 PD patients from Queensland to 1078 consecutive Australian male newborns from Victoria. We confirmed the earlier finding by observing a significant excess of GZ alleles in PD (4.8%) compared to controls (1.5%). Although both studies provided evidence in support of an association between GZ‐carrier status and increased risk for parkinsonism, the existing evidence in the literature from screening studies remains equivocal and we discuss the need for alternative approaches to resolve the issue. 相似文献
76.
Rashid Ghaznawi Maarten HT Zwartbol Nicolaas PA Zuithoff Jeroen de Bresser Jeroen Hendrikse Mirjam I Geerlings 《Journal of cerebral blood flow and metabolism》2021,41(6):1229
Global cerebral hypoperfusion may be involved in the aetiology of brain atrophy; however, long-term longitudinal studies on this relationship are lacking. We examined whether reduced cerebral blood flow was associated with greater progression of brain atrophy. Data of 1165 patients (61 ± 10 years) from the SMART-MR study, a prospective cohort study of patients with arterial disease, were used of whom 689 participated after 4 years and 297 again after 12 years. Attrition was substantial. Total brain volume and total cerebral blood flow were obtained from magnetic resonance imaging scans and expressed as brain parenchymal fraction (BPF) and parenchymal cerebral blood flow (pCBF). Mean decrease in BPF per year was 0.22% total intracranial volume (95% CI: –0.23 to –0.21). Mean decrease in pCBF per year was 0.24 ml/min per 100 ml brain volume (95% CI: –0.29 to –0.20). Using linear mixed models, lower pCBF at baseline was associated with a greater decrease in BPF over time (p = 0.01). Lower baseline BPF, however, was not associated with a greater decrease in pCBF (p = 0.43). These findings indicate that reduced cerebral blood flow is associated with greater progression of brain atrophy and provide further support for a role of cerebral blood flow in the process of neurodegeneration. 相似文献
77.
78.
79.
80.
Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody 总被引:1,自引:1,他引:1
Vervoordeldonk SF; Merle PA; van Leeuwen EF; van der Schoot CE; von dem Borne AE; Slaper-Cortenbach IC 《Blood》1994,83(6):1632-1639
Antigenic modulation is one of many factors determining the effectiveness of monoclonal antibody (MoAb)-mediated therapy. To select the isotype of a CD19 MoAb most suitable for radioimmunotherapy of patients with B-cell malignancies, we studied the influence of MoAb isotype on modulation, after binding of the MoAb to different cell-line cells. The CD19-IgG1 MoAb was found to induce modulation of CD19 antigens on Daudi cell line cells more rapidly than did its IgG2a switch variant. We provide evidence that this difference in modulation rate is caused by the expression of Fc gamma receptor II (Fc gamma RII) on these cells. Experiments aimed at elucidating the mechanism of Fc gamma RII involvement in modulation induction by CD19-IgG1 showed that Fc gamma RII did not comodulate with CD19 MoAbs. However, cocrosslinking of CD19 and Fc gamma RII with CD19-IgG1 MoAb resulted in enhanced calcium mobilization in Daudi cells. This increased signal induction accompanies the enhanced capping and subsequent modulation of CD19 antigens. Because Fc gamma RII is expressed in varying densities on malignant B cells in all differentiation stages, our results have implications for the MoAb isotype most suitable for use in MoAb-based therapy of patients with B-cell malignancies. 相似文献